secwatch.observer — SEC 8-K summary
======================================

Issuer:     USANA HEALTH SCIENCES INC (USNA)
CIK:        0000896264
Form:       8-K
Filed at:   2021-10-26T23:59:59+00:00
Accession:  0001157523-21-001255
Event type: earnings
Sentiment:  neutral
Materiality: 0.60
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

USANA Q3 net sales $274.4M, EPS $1.36; reiterates FY2021 outlook
----------------------------------------------------------------

- Net sales $274.4M (-8% YoY); diluted EPS $1.36 (-6% YoY).
- Active customers 576,000 (-11% YoY); Greater China active customers -13% YoY.
- Reiterates FY2021 net sales $1.18-$1.20B, EPS $5.80-$6.00; expects ~$130M free cash flow.
- Cash $249M, no debt; repurchased 523k shares for $50M, $137M remaining under authorization.
- Supply chain disruptions and inflationary pressures continue; product launches delayed to 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/896264/000115752321001255/0001157523-21-001255-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/896264/000115752321001255/a52516018.htm
  HTML page:      https://secwatch.observer/filing/0001157523-21-001255

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer